NQVAX | VEVYX | NQVAX / VEVYX | |
Total Expense Ratio | 1.16 | 0.66 | 176% |
Annual Report Gross Expense Ratio | 1.17 | 0.66 | 177% |
Fund Existence | 23 years | 13 years | - |
Gain YTD | 11.001 | 0.751 | 1,464% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 707M | 16.6B | 4% |
Annual Yield % from dividends | 1.16 | 1.02 | 114% |
Returns for 1 year | 10.31 | -12.29 | -84% |
Returns for 3 years | 61.75 | 7.07 | 873% |
Returns for 5 years | 123.81 | 31.88 | 388% |
Returns for 10 years | 176.89 | 48.25 | 367% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LRGG | 29.26 | 0.22 | +0.76% |
Macquarie Focused Large Growth ETF | |||
FLJP | 35.18 | 0.16 | +0.46% |
Franklin FTSE Japan ETF | |||
MAPP | 26.44 | 0.04 | +0.15% |
Harbor Multi-Asset Explorer ETF | |||
XJR | 41.98 | 0.04 | +0.08% |
iShares ESG Select Scrn S&P Small-CapETF | |||
SPSK | 18.57 | -0.02 | -0.11% |
SP Funds Dow Jones Global Sukuk ETF |